EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study

Rong Qin, Yibei Liu, Rui Ding, Minhui Yang, Yun Huang, Xujia Chen, Feng Zhang, Yanting Liu, Hongping Jia, Yiyao Duan, Lifang Zhou, Hui Wang

Lipids in Health and Disease · 2025

DOI: 10.1186/s12944-025-02448-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Lipids in Health and Disease, 2025. Verfasst von Rong Qin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650051, China. Hauptthemen laut MEDLINE: Pancreatitis, Plasmapheresis, Hyperlipidemias. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Joint Special Funds for the Department of Science and Technology of Yunnan Province Kunming Medical University, Health Research Project of Kunming Municipal Health Commission, Kunming Health Science and Technology Personnel Training Project-Medical science and technology leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study examines the role and effectiveness of double filtration plasmapheresis (DFPP) in managing hyperlipidemiclipidemic acute pancreatitis (HLAP). METHODS: Comparative analysis was conducted between two groups: one treated with DFPP and one without. Comparative parameters included blood lipid levels, inflammatory factors, vital signs, disease severity scores, and complication rates. RESULTS: A total of 97 HLAP patients were included in the study. Within-group analysis revealed significant pre- and post-treatment changes in total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), white blood cell count (WBC), neutrophil percentage (N%), systemic immune-inflammation index (SII), mean arterial pressure (MAP), bedside index for severity in acute pancreatitis (BISAP), and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores in the DFPP group (P < 0.05). In contrast, the without DFPP group showed significant changes in TC, TG, LDL-C, WBC, N%, SII, systemic inflammation response index (SIRI), panimmune-inflammation value (PIV), respiration rate (RR), and APACHE II scores (P < 0.05). Significant differences in TC, TG, HDL-C, LDL-C, and RR were found between the DFPP and without DFPP groups (P < 0.05). The DFPP group exhibited greater reductions in TG levels and more individual variability. In terms of complications, the rate of systemic inflammatory response syndrome (SIRS) differed significantly between the groups (P < 0.05). CONCLUSIONS: DFPP can significantly improve short-term outcomes, reduce lipid levels, and reduce the incidence of complications such as SIRS in HLAP patients compared with those not receiving DFPP treatment. The clinical utility of DFPP is considerable, and further exploration and implementation of this method are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisPlasmapheresisHyperlipidemiasHumansFemaleMaleMiddle AgedRetrospective StudiesAdultTriglyceridesCholesterol, LDLCholesterol, HDLAgedAPACHEAcute DiseaseTreatment Outcome

Stichwörter der Autor:innen

Double filtration plasmapheresisHyperlipidemic acute pancreatitisTreatment outcome

Substanzen

TriglyceridesCholesterol, LDLCholesterol, HDL

Autor:innen und Institutionen

  • Department of Gastroenterology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650051, China.
  • Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, 650051, China.
  • Department of Gastroenterology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650051, China. 707192403@qq.com.
  • Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, 650051, China. 707192403@qq.com.
  • Department of Gastroenterology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650051, China. Amyhxy126@163.com.
  • Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, 650051, China. Amyhxy126@163.com.

Förderung

  • Joint Special Funds for the Department of Science and Technology of Yunnan Province Kunming Medical University
  • Health Research Project of Kunming Municipal Health Commission
  • Kunming Health Science and Technology Personnel Training Project-Medical science and technology leader
  • Yunnan Provincial Education Department Scientific Research Fund
  • Kunming Health Science and Technology Personnel Training Project-Leading talents in medical science and technology

Zitieren

APA

Qin, R., Liu, Y., Ding, R., Yang, M., Huang, Y., Chen, X., Zhang, F., Liu, Y., Jia, H., Duan, Y., Zhou, L., & Wang, H. (2025). Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study. Lipids in Health and Disease. https://doi.org/10.1186/s12944-025-02448-2

Vancouver

Qin R, Liu Y, Ding R, Yang M, Huang Y, Chen X, et al. Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study. Lipids in Health and Disease. 2025. doi:10.1186/s12944-025-02448-2

BibTeX
@article{Qin2025,
  author = {Qin, Rong and Liu, Yibei and Ding, Rui and Yang, Minhui and Huang, Yun and Chen, Xujia and Zhang, Feng and Liu, Yanting and Jia, Hongping and Duan, Yiyao and Zhou, Lifang and Wang, Hui},
  title = {Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study},
  journal = {Lipids in Health and Disease},
  year = {2025},
  doi = {10.1186/s12944-025-02448-2}
}
Kostenlos starten →